IBM and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management

Reuters

06-02

<a href="https://laohu8.com/S/IBM">IBM</a> and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management

IBM and Roche have teamed up to develop an AI-enabled solution aimed at easing the daily management of diabetes. This innovative partnership has resulted in the creation of Roche's Accu-Chek SmartGuide Predict app, which utilizes AI technology to provide glucose predictions and assist individuals with diabetes in managing their condition more effectively. Highlighting the importance of cross-industry collaboration, this solution is being showcased at the Swiss Economic Forum in Interlaken. Additionally, IBM and Roche have developed a tool to expedite the analysis of clinical study data, leveraging advanced technologies to enhance study workflows. This collaboration underscores the potential of combining technological expertise with healthcare innovation to address unmet needs and improve patient outcomes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBM - International Business Machines Corporation published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2540689877"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2540689877\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2540689877?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-02 15:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2540689877","market":"us","top_or_hot":-1,"title":"IBM and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IBM\">IBM</a> and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IBM and Roche have teamed up to develop an AI-enabled solution aimed at easing the daily management of diabetes. This innovative partnership has resulted in the creation of Roche's Accu-Chek SmartGuide Predict app, which utilizes AI technology to provide glucose predictions and assist individuals with diabetes in managing their condition more effectively. Highlighting the importance of cross-industry collaboration, this solution is being showcased at the Swiss Economic Forum in Interlaken. Additionally, IBM and Roche have developed a tool to expedite the analysis of clinical study data, leveraging advanced technologies to enhance study workflows. This collaboration underscores the potential of combining technological expertise with healthcare innovation to address unmet needs and improve patient outcomes.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBM - International Business Machines Corporation published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IBM and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIBM and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-06-02 15:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IBM\">IBM</a> and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IBM and Roche have teamed up to develop an AI-enabled solution aimed at easing the daily management of diabetes. This innovative partnership has resulted in the creation of Roche's Accu-Chek SmartGuide Predict app, which utilizes AI technology to provide glucose predictions and assist individuals with diabetes in managing their condition more effectively. Highlighting the importance of cross-industry collaboration, this solution is being showcased at the Swiss Economic Forum in Interlaken. Additionally, IBM and Roche have developed a tool to expedite the analysis of clinical study data, leveraging advanced technologies to enhance study workflows. This collaboration underscores the potential of combining technological expertise with healthcare innovation to address unmet needs and improve patient outcomes.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBM - International Business Machines Corporation published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1585245621.USD","symbol_name":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL4cMjD4:1","article_id":"2540689877","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2540689877","pubTimestamp":1748847672,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IBM and Roche have teamed up to develop an AI-enabled solution aimed at easing the daily management of diabetes. This innovative partnership has resulted in the creation of Roche's Accu-Chek SmartGuide Predict app, which utilizes AI technology to provide glucose predictions and assist individuals with diabetes in managing their condition more effectively. Highlighting the importance of cross-industry collaboration, this solution is being showcased at the Swiss Economic Forum in Interlaken. Additionally, IBM and Roche have developed a tool to expedite the analysis of clinical study data, leveraging advanced technologies to enhance study workflows. This collaboration underscores the potential of combining technological expertise with healthcare innovation to address unmet needs and improve patient outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4612":"AI芯片","IBM":"IBM","LU1880398471.USD":"AMUNDI FUNDS GLOBAL EQUITY \"A2\" (USD) ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1880398554.USD":"AMUNDI FUNDS GLOBAL EQUITY \"A2\" (USD) INC","BK4602":"量子计算概念","BK4533":"AQR资本管理(全球第二大对冲基金)","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","BK4575":"芯片概念","BK4543":"AI","BK4538":"云计算","BK4579":"人工智能","BK4588":"碎股","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4134":"信息科技咨询与其它服务","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC"},"translate_title":"IBM与罗氏合作推出支持AI的血糖预测解决方案，用于糖尿病管理","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBM":0.9},"content_text":"IBM and Roche Partner to Launch AI-Enabled Glucose Prediction Solution for Diabetes Management\n    \n\n        IBM and Roche have teamed up to develop an AI-enabled solution aimed at easing the daily management of diabetes. This innovative partnership has resulted in the creation of Roche's Accu-Chek SmartGuide Predict app, which utilizes AI technology to provide glucose predictions and assist individuals with diabetes in managing their condition more effectively. Highlighting the importance of cross-industry collaboration, this solution is being showcased at the Swiss Economic Forum in Interlaken. Additionally, IBM and Roche have developed a tool to expedite the analysis of clinical study data, leveraging advanced technologies to enhance study workflows. This collaboration underscores the potential of combining technological expertise with healthcare innovation to address unmet needs and improve patient outcomes.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IBM - International Business Machines Corporation published the original content used to generate this news brief on May 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}